ATC code J06
| ATC code J: Antiinfectives for systemic use | 
|---|
  | 
| Human only | 
| ATCvet only | 
  | 
| Other ATC codes | 
ATC code J06 Immune sera and immunoglobulins is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup J06 is part of the anatomical group J Antiinfectives for systemic use.[4]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
J06A Immune sera
J06AA Immune sera
- J06AA01 Diphtheria antitoxin
 - J06AA02 Tetanus antitoxin
 - J06AA03 Snake venom antiserum
 - J06AA04 Botulinum antitoxin
 - J06AA05 Gas-gangrene sera
 - J06AA06 Rabies serum
 
J06B Immunoglobulins
J06BA Immunoglobulins, normal human
- J06BA01 Immunoglobulins, normal human, for extravascular administration
 - J06BA02 Immunoglobulins, normal human, for intravascular administration
 
J06BB Specific immunoglobulins
- J06BB01 Anti-D (rh) immunoglobulin
 - J06BB02 Tetanus immunoglobulin
 - J06BB03 Varicella/zoster immunoglobulin
 - J06BB04 Hepatitis B immunoglobulin
 - J06BB05 Rabies immunoglobulin
 - J06BB06 Rubella immunoglobulin
 - J06BB07 Vaccinia immunoglobulin
 - J06BB08 Staphylococcus immunoglobulin
 - J06BB09 Cytomegalovirus immunoglobulin
 - J06BB10 Diphtheria immunoglobulin
 - J06BB11 Hepatitis A immunoglobulin
 - J06BB12 Encephalitis, tick-borne immunoglobulin
 - J06BB13 Pertussis immunoglobulin
 - J06BB14 Morbilli immunoglobulin
 - J06BB15 Parotitis immunoglobulin
 - J06BB19 Anthrax immunoglobulin
 - J06BB30 Combinations
 
J06BC Antibacterial monoclonal antibodies
- J06BC01 Nebacumab
 - J06BC02 Raxibacumab
 - J06BC03 Bezlotoxumab
 - J06BC04 Obiltoxaximab
 
J06BD Antiviral monoclonal antibodies
- J06BD01 Palivizumab
 - J06BD02 Motavizumab
 - J06BD03 Tixagevimab and cilgavimab
 - J06BD04 Ansuvimab
 - J06BD05 Sotrovimab
 - J06BD06 Regdanvimab
 - J06BD07 Casirivimab and imdevimab
 - J06BD08 Nirsevimab
 
See also
References
- ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
 - ↑ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
 - ↑ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
 - ↑ "ATC/DDD Index 2022: code J06". WHO Collaborating Centre for Drug Statistics Methodology.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.